Universe Pharmaceuticals INC (UPC) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
UPC currently has 23.6M outstanding shares. with significant dilution risk as 25M authorized shares could dilute existing holders by 105.7%. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 29, 2025 |
20-F filing | 23.6M shares outstanding |
24M | 25M |
| Apr 24, 2024 |
F-1 filing: This is an F-1 filing for an offering of ordinary shares with a proposed price of $1.25 per share. The company intends to use the net proceeds from this offering for general corporate purposes. |
3.6M | 25M |
| Jan 30, 2024 |
20-F filing | 3.6M shares outstanding |
3.6M | 5M |
| Feb 10, 2023 |
20-F filing | 21.8M shares outstanding |
22M | 5M |
| Oct 27, 2022 |
F-3 filing: This is an F-3 filing for an offshore holding company incorporated in the Cayman Islands, offering securities to investors, with operations conducted in China through a wholly owned indirect PRC subsidiary. |
22M | 5M |
| Jan 31, 2022 |
20-F filing | 21.8M shares outstanding |
22M | 5M |
| Aug 17, 2020 |
F-1 filing: This is an F-1 filing for an IPO of Ordinary Shares by Universe Pharmaceuticals INC. |
16M | 5M |